104 related articles for article (PubMed ID: 21957877)
1. X-ray fluorescence elemental mapping and microscopy to follow hepatic disposition of a Gd-based magnetic resonance imaging contrast agent.
Delfino R; Altissimo M; Menk RH; Alberti R; Klatka T; Frizzi T; Longoni A; Salomè M; Tromba G; Arfelli F; Clai M; Vaccari L; Lorusso V; Tiribelli C; Pascolo L
Clin Exp Pharmacol Physiol; 2011 Dec; 38(12):834-45. PubMed ID: 21957877
[TBL] [Abstract][Full Text] [Related]
2. Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats.
Clément O; Mühler A; Vexler V; Berthezène Y; Brasch RC
Invest Radiol; 1992 Aug; 27(8):612-9. PubMed ID: 1428739
[TBL] [Abstract][Full Text] [Related]
3. [A comparative study between Gd-BOPTA, a biliary excretion contrast medium, and Gd-DTPA in the magnetic resonance imaging of the rat liver].
Patrizio G; Pavone P; Cardone G; Pietroletti R; Passariello R; Tettamanti E; Musu C; Felder E
Radiol Med; 1990 May; 79(5):458-62. PubMed ID: 2359853
[TBL] [Abstract][Full Text] [Related]
4. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
[TBL] [Abstract][Full Text] [Related]
5. Gadolinium-enhanced imaging of liver tumors and manifestations of hepatitis: pharmacodynamic and technical considerations.
Sharma P; Kitajima HD; Kalb B; Martin DR
Top Magn Reson Imaging; 2009 Apr; 20(2):71-8. PubMed ID: 20010061
[TBL] [Abstract][Full Text] [Related]
6. In vivo MR/optical imaging for gastrin releasing peptide receptor of prostate cancer tumor using Gd-TTDA-NP-BN-Cy5.5.
Lin YH; Dayananda K; Chen CY; Liu GC; Luo TY; Hsu HS; Wang YM
Bioorg Med Chem; 2011 Feb; 19(3):1085-96. PubMed ID: 20493715
[TBL] [Abstract][Full Text] [Related]
7. Gd-DISIDA--a potential contrast agent for magnetic resonance imaging of the hepatobiliary system.
Saha GB; Bateson BP; Meaney TF; Ng TC; Go RT; MacIntyre WJ; Feiglin DH; O'Donnell JK
J Nucl Med Allied Sci; 1989; 33(1):1-6. PubMed ID: 2746364
[TBL] [Abstract][Full Text] [Related]
8. Cerebral blood volume quantification in a C6 tumor model using gadolinium per (3,6-anhydro) alpha-cyclodextrin as a new magnetic resonance imaging preclinical contrast agent.
Lahrech H; Perles-Barbacaru AT; Aous S; Le Bas JF; Debouzy JC; Gadelle A; Fries PH
J Cereb Blood Flow Metab; 2008 May; 28(5):1017-29. PubMed ID: 18183033
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of gadoxetate disodium as a contrast agent for mouse liver imaging: comparison with gadobenate dimeglumine.
Kiryu S; Inoue Y; Watanabe M; Izawa K; Shimada M; Tojo A; Yoshikawa K; Ohtomo K
Magn Reson Imaging; 2009 Jan; 27(1):101-7. PubMed ID: 18599243
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics in rats, dogs and monkeys of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging.
Schuhmann-Giampieri G; Frenzel T; Schmitt-Willich H
Arzneimittelforschung; 1993 Aug; 43(8):927-31. PubMed ID: 8216456
[TBL] [Abstract][Full Text] [Related]
11. Multinodular focal fatty infiltration of the liver: atypical imaging findings on delayed T1-weighted Gd-BOPTA-enhanced liver-specific MR images.
Marin D; Iannaccone R; Catalano C; Passariello R
J Magn Reson Imaging; 2006 Sep; 24(3):690-4. PubMed ID: 16878304
[TBL] [Abstract][Full Text] [Related]
12. Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects.
Dahlström N; Persson A; Albiin N; Smedby O; Brismar TB
Acta Radiol; 2007 May; 48(4):362-8. PubMed ID: 17453513
[TBL] [Abstract][Full Text] [Related]
13. Gadocoletic acid trisodium salt (b22956/1): a new blood pool magnetic resonance contrast agent with application in coronary angiography.
de Haën C; Anelli PL; Lorusso V; Morisetti A; Maggioni F; Zheng J; Uggeri F; Cavagna FM
Invest Radiol; 2006 Mar; 41(3):279-91. PubMed ID: 16481911
[TBL] [Abstract][Full Text] [Related]
14. Molecular determinants in the transport of a bile acid-derived diagnostic agent in tumoral and nontumoral cell lines of human liver.
Libra A; Fernetti C; Lorusso V; Visigalli M; Anelli PL; Staud F; Tiribelli C; Pascolo L
J Pharmacol Exp Ther; 2006 Nov; 319(2):809-17. PubMed ID: 16895978
[TBL] [Abstract][Full Text] [Related]
15. Quantitative imaging of cell-permeable magnetic resonance contrast agents using x-ray fluorescence.
Endres PJ; Macrenaris KW; Vogt S; Allen MJ; Meade TJ
Mol Imaging; 2006; 5(4):485-97. PubMed ID: 17150161
[TBL] [Abstract][Full Text] [Related]
16. The gadolinium complexes with polyoxometalates as potential MRI contrast agents.
Li Z; Li W; Li X; Pei F; Li Y; Lei H
Magn Reson Imaging; 2007 Apr; 25(3):412-7. PubMed ID: 17371733
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the distribution of MRI contrast agents in the livers of small animals by means of complementary microscopies.
Kahn E; Tessier C; Lizard G; Petiet A; Bernengo JC; Coulaud D; Fourré C; Frouin F; Clément O; Jourdain JR; Delain E; Guiraud-Vitaux F; Colas-Linhart N; Siauve N; Cuenod CA; Frija G; Todd-Pokropek A
Cytometry A; 2003 Feb; 51(2):97-106. PubMed ID: 12541284
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of [Gd(Bz-TTDA)]2- as a potential contrast agent in MR imaging of the hepatobiliary system: an animal study.
Hsu JS; Jaw TS; Liu GC; Wang YM; Chen SH; Kuo YT; Jao JC; Li CW; Tsai KB
J Magn Reson Imaging; 2004 Oct; 20(4):632-9. PubMed ID: 15390149
[TBL] [Abstract][Full Text] [Related]
19. In vivo MRI and ex vivo quantification of iron and Kupffer cells demonstrate residual phagocytic activity in mouse liver after a gadolinium chloride injection.
Fabre M; Leroy-Willig A; Denis CV; Ba N; Schoëvaërt D; Guettier C; Geldwerth-Feniger D
Biochimie; 2010 Oct; 92(10):1343-53. PubMed ID: 20600563
[TBL] [Abstract][Full Text] [Related]
20. Liver. III: Gadolinium-based hepatobiliary contrast agents (Gd-EOB-DTPA and Gd-BOPTA/Dimeg).
Giovagnoni A; Paci E
Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):61-72. PubMed ID: 8673717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
